Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

by admin April 16, 2025
April 16, 2025
Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

A top advisor to Defense Secretary Pete Hegseth was escorted out of the Pentagon on Tuesday and placed on administrative leave, according to a Defense Department official. 

Reuters first reported Caldwell had been placed on leave for an ‘unauthorized disclosure’ of information amid an investigation into Pentagon leaks. An official confirmed to Fox News Digital that Reuters’ reporting is accurate but declined to comment on an ongoing investigation. 

Caldwell previously worked at restraint-minded think tank Defense Priorities and Concerned Veterans for America, a group formerly led by Hegseth. A foreign policy realist, he has argued that the U.S. should dramatically reduce its footprint in Europe and pull out forces in Iraq and Syria. 

Last month, the Defense Department announced a probe into ‘recent unauthorized disclosures of national security information’ and said it planned to use polygraphs to determine the source of leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution.

Caldwell did not immediately reply to a request for comment. 

Caldwell’s closeness to the defense secretary was underscored in the unintentionally leaked Signal chat on Houthi strikes, where Hegseth named him as the Pentagon point of contact for the offensive campaign. 

This post appeared first on FOX NEWS

previous post
Soaring Medicare prescription drug prices targeted in Trump’s new executive order
next post
Schumer calls on Leland Dudek, acting commissioner of SSA, to resign

related articles

Trump’s ‘Art of the Deal’ diplomacy just delivered...

May 11, 2025

Turning Point USA expands its merchandise collection with...

September 18, 2025

Dems’ Gaetz outrage follows long history of questionable...

November 19, 2024

Donald Trump sentenced with no penalty in New...

January 11, 2025

Trump’s Greenland push drives Danish prime minister to...

February 27, 2026

DAVID MARCUS: How Trump’s team of former rivals...

January 10, 2026

UN Human Rights Council chief cuts off speaker...

February 28, 2026

US approves massive arms sales to Israel and...

January 31, 2026

Supreme Court rules DOGE can access Social Security...

June 7, 2025

Some House Republicans privately furious at Musk, Ramaswamy...

December 20, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 2

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 3

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 4

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024
    • 5

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,600)
    • Stocks (1,404)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved